Ceptyr
About:
Ceptyr is a developer of protein tyrosine phosphatase (PTP) -based therapeutics.
Website: http://www.ceptyr.com
Top Investors: ARCH Venture Partners, Lombard Odier, Cascade Investment, GeneChem, Tredegar Investments
Description:
Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.
Total Funding Amount:
$31.5M
Headquarters Location:
Bothell, Washington, United States
Founded Date:
1995-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2002-12-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai